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Prevention of hemodialysis-related muscle
cramps by intradialytic use of sequential
compression devices: A report of four cases
Muhammad AHSAN, Mini GUPTA, Irfan OMAR, Stanley FRINAK, Suzette GENDJAR,
Yayha OSMAN-MALIK, Jerry YEE
Division of Nephrology and Hypertension, Department of Medicine, Henry Ford Health System, Detroit,
Michigan, U.S.A.

Abstract
Background: Hemodialysis (HD)-related lower extremity (LE) muscle cramps are a common cause of
morbidity in end-stage renal disease patients on maintenance HD. Numerous pharmacologic and
physical measures have been tried with variable success rates.
Methods: Sequential compression devices (SCD) improve venous return (VR) and are commonly used
to prevent LE deep venous thrombosis in hospitals. We hypothesized that LE cramps are triggered by
stagnant venous flow during HD and are preventable by improving VR. We prospectively studied four
adult patients (mean age 61  14 years) on thrice-weekly HD who experienced two or more episodes
of LE cramping weekly in the month before the study. SCD were applied before each HD on both legs
and compressions were intermittently applied at 40 mmHg during treatment.
Results: All four patients reported complete resolution of cramping during the study period that
lasted 1 month or 12 consecutive dialysis treatments.
Conclusion: Application of SCD to LE may prevent the generation of LE HD-related cramping in a select
group of patients. Larger, controlled studies are needed to establish the utility of this noninvasive
alternative for the prevention of LE HD-related cramps.

INTRODUCTION
Hemodialysis (HD)-related lower extremity (LE) cramps
remain a common cause of morbidity during dialysis.
According to one report, the most frequent reason for discontinuation of HD treatments prematurely was muscle
cramps.1 The precise incidence is uncertain, but in one
study at least 23% of patients reported occurrence of cramps
during dialysis.2 The etiology of this condition is not exactly
established; however, dialysis induced volume contraction
and hypoosmolality are common predisposing factors.3
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Although any muscle group can be involved, cramps typically involve the legs, feet, abdominal wall, and hands. LE
cramps seem to be the most common. Delayed cramps
are also observed and may occur for several hours after
the end of dialysis.4 Muscle cramps are often preceded
by hypotension, although they can persist even after
restoration of adequate blood pressure (BP). In a minority
of patients cramps during dialysis may occur without
any hypotension.5 HD adequacy may be compromised
when cramps and associated hypotension is treated by
temporarily decreasing blood flow, ultrafiltration (UF) or
even stopping dialysis treatment. Elective use of a highdialysate sodium concentration or saline administration
to stabilize BP to ameliorate cramps and hypotension
results in increased thirst and aggravation of interdialytic
hypertension.6
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Numerous pharmacologic therapies to improve or prevent muscle cramps have been reported in the literature.
These include hypertonic saline,7 quinine sulfate,8 50%
dextrose water, 25% mannitol,9,10 vitamin E,11 chloroquine phosphate,12 L-carnitine,13 and low-dose prazosin.14
Response to head-up tilt15 and various stretching exercises
of the LE16 are some of the few nonpharmacologic modalities studied so far.
Sequential compression devices (SCD) improve venous
return (VR) and are commonly used to prevent LE deep
venous thrombosis (DVT) in hospitalized nonambulatory
patients. We hypothesized that LE dialysis-related cramps
are triggered by stagnant venous flow during dialysis and
are preventable by improving VR. This pilot study was the
first effort to evaluate the feasibility of intradialytic SCD
use for the prevention of HD-related LE cramps.

CASES AND METHODS
Patient selection
Two-hundred patients undergoing three-times-weekly
HD at Henry Ford Hospital/Greenfield Health System’s
West Pavilion dialysis were interviewed and their dialysis
records were reviewed for documented episodes and
number of LE cramps. Inclusion criteria were two or
more episodes of LE cramps during or after dialysis
each week for the previous 4 weeks (pre-SCD period),
ability to give informed consent, at least 6 months on
dialysis therapy, and a stable dry weight the month before
the study period.
Patients with severe atherosclerosis of LE, congestive
heart failure, known history of DVT, or any local condition interfering with the application SCDs like open
wound or dermatitis were excluded. Muscle cramps
were defined as contraction of large muscle group of LE
sufficiently painful requiring an intervention by the dialysis nurse for relief. Four patients met the above-noted
criteria and enrolled and studied for 1 month with SCD
application before each HD (post-SCD period). The study
was approved by the Institutional review board of the
Henry Ford Health system, Detroit Michigan. All patients
gave informed consents.

Treatment protocol
During the study phase, at the onset of each dialysis SCD,
also known as calf garment DVT 10 or simply Flowtron
(Huntleigh, Manalapan, NJ), were wrapped firmly around
both calves and compressions were intermittently applied
at 40 mmHg throughout the treatment. Frequencies of the
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compressions were three cycles of compressions and
decompressions per minute. Each cycle of compression
and decompression lasted for approximately 10 sec.
Lower extremities of all patients were kept horizontal
during each dialysis session. Patients were monitored
for location and severity of cramps during each dialysis
session. The usually monitored dialysis parameters such
as pre- and postdialysis weights, BP—reported as mean
arterial pressure—and UF were also recorded for each
treatment. Episodes of intradialytic hypotension (IDH)
were carefully recorded. IDH was defined as a sudden
drop in systolic BP (SBP) of 20 mmHg, SBP 90 mmHg, or
any decrease in BP requiring nursing intervention including saline bolus, intravenous albumin, a decrease in or
termination of UF, or placement of patient in Trendelenburg position. Dialysate temperature remained
unchanged during both phases at 37 C. The HD prescription including the duration of treatment, dialysate
composition, and antihypertensive therapy remained
unchanged during both phases.

Case reports
Comparative clinical data of cases are presented in Table 1.

Case 1
A 59-year-old African American (AA) male who initiated
maintenance dialysis 4 years ago due to the development
of end-stage renal disease from hypertensive nephrosclerosis. He is being dialyzed from forearm arteriovenous
(AV) graft. He reported daily LE cramping during the preSCD period without any documented IDH. During the
post-SCD phase he remained totally asymptomatic without LE cramping and had no IDH. His dry weight and
antihypertensive therapy remained unchanged.
Case 2
A 66-year-old AA woman on maintenance HD for 9 years
due to diabetic glomerulosclerosis, now from a cuffed
catheter. She reported 13 episodes of LE cramping during
the pre-SCD phase and no LE cramps, but two episodes
of hand cramping during the post-SCD phase. There was
no IDH in either period. Her dry weight and BP medications remained unchanged.
Case 3
A 43-year-old AA man on HD for 4 years due to hypertensive nephrosclerosis. He has an AV graft. He had almost
daily severe LE cramping in the pre-SCD phase, but did
not experience a single episode of LE cramping during the
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Table 1 Comparative clinical data of cases
Clinical characteristics

Case 1

Case 2

Case 3

Case 4

Age (years)
Sex/race
Dry weight (kg)
Pre-SCD (N ¼ 12)
Post-SCD (N ¼ 12)
No. of cramps
Pre-SCD (N ¼ 12)
Post-SCD (N ¼ 12)
Average UF (L)
Pre-SCD (N ¼ 12)
Post-SCD (N ¼ 12)
Intradialytic hypotension
Pre-SCD (N ¼ 12)
Post-SCD (N ¼ 12)

59
M/AA

66
F/AA

43
M/AA

78
F/AA

69.5
69.5

58
58

66
65

68.5
71.5

12
0

13
0a

9
0

8
0

4.4
5.0

2.6
2.3

3.3
3.1
No
No

3.0
2.9
No
No

No
No

Yes
Yes

a

Reported two episodes of hand cramps.
M ¼ male; F ¼ female; AA ¼ African American; SCD ¼ sequential compression device; UF ¼ ultrafiltration.

post-SCD phase. There was no IDH and his dry weight was
in fact decreased from 66 to 65 kg during the post-SCD
period although his BP medications were not changed.

Case 4
A 78-year-old AA woman on HD for 2 years due to
hypertensive nephrosclerosis and has an AV graft. She
was experiencing daily LE cramps lasting for a few hours
after every dialysis during the pre-SCD phase but
reported complete resolution during the post-SCD
phase. Her dry weight was gradually increased from
68.5 to 71.5 kg during the post-SCD period due to IDH
(without cramps). She, however, continues to develop
sudden episodes of IDH.

DISCUSSION
The exact mechanism of HD-related cramping is not
known. Previous studies have shown that both flow and
permeability contribute to intercompartmental solute
clearance.17 There is a reduction in slow intercompartmental clearance of urea during dialysis.18 It is likely that
VR drops during dialysis due to nonambulation and the
often dependent position of the lower extremities. This
stagnation of blood flow could result in accumulation and
delayed clearance of various ‘‘cramp-inducing metabolites’’ and creates a favorable milieu for cramp generation
in a small subgroup of patients. Dialysis induced
decreases in the red blood cell 2,3-diphosphoglycerate
and increases in the arterial pH may result in less oxygen
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delivery to tissues because of increased hemoglobinoxygen affinity; therefore, it has been suggested that
HD-associated muscle cramps could be a manifestation
of acute oxygen deficiency in muscles.19
SCD provides intermittent compressions to the calf muscles and in fact acts like an external venous pump and was
effective in preventing cramps. We applied intermittent
compressions at a pressure of 40 mmHg, which was sufficient to improve the VR and would not have caused arterial
compromise. We are not certain about the exact mechanism of prevention of LE cramps, but it appears that venous
pooling in LE plays a role in causation and improving the
VR by external compressions prevented this painful condition. The patients’ medications, especially antihypertensive
therapy, remained unchanged during both study phases.
This suggests that the main factor that contributed to the
cramp prevention was the improved VR.
We propose that intradialytic venous pooling in LE
creates a favorable environment for cramp generation in
susceptible patients and application of intermittent external calf compressions during dialysis is a useful maneuver, which can prevent LE cramps by improving VR.
Larger controlled studies are needed to establish the role
of this potentially useful noninvasive modality for the
prevention of LE HD-related cramps.
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